Anavex Life Sciences Corp.
AVXL
Health Care
2
exclusion reasons
1 theme
Anavex Life Sciences Corp. is screened out under 2 exclusion reasons spanning 1 issue category.
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. It is a statement of values.
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company whose drug development pipeline relies on preclinical testing in animal models. The company’s research into its lead investigational compounds, including ANAVEX®3-71 for neurodegenerative diseases, involves studies in aged transgenic animal models to measure cognitive and functional outcomes. This use of animals in biomedical research is a core, non-optional component of its regulatory development pathway. The company’s Supplier Code of Conduct references responsible business practices but does not provide evidence of a corporate policy or commitment to eliminate animal testing from its research and development activities.
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company whose drug development pipeline necessitates animal testing for regulatory compliance. The company’s lead drug candidate, ANAVEX®2-73 (blarcamesine), has progressed through Phase 2a and Phase 2b/3 clinical trials for Alzheimer’s disease. As disclosed in its 2025 Form 10-K, the company’s non-clinical testing includes laboratory evaluation of potential drug compounds and animal studies to assess chemistry, formulation, and toxicity. This reliance on animal data is a standard, required step for advancing therapeutic candidates through the regulatory approval process. The company’s Supplier Code of Conduct references corporate integrity but does not articulate a policy against animal testing.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.